Table 2 Statistical values and distribution of drug-related macular edema
From: Drug-related macular edema: a real-world FDA Adverse Event Reporting System database study
Drug Classification | Drug Name | N | ROR (95% Cl) | PRR (χ2) | MGPS (95% CI Lower) | BCPNN (95% CI Lower) |  |
|---|---|---|---|---|---|---|---|
Ophthalmology | Latanoprost | 5 | 5.51 (2.29–13.27) | 5.51 (18.41) | 5.50 (2.64) | 2.46 (2.44) |  |
Non-Ophthalmic | Fingolimod | 303 | 30.69 (27.14–34.7) | 30.56 (7315.71) | 25.96 (23.42) | 4.7 (3.03) |  |
Non-Ophthalmic | Cefuroxime | 66 | 75.93 (59.32–97.2) | 75.04 (4658.45) | 72.52 (58.99) | 6.18 (4.51) |  |
Non-Ophthalmic | Protein-Bound Paclitaxel | 23 | 14.82 (9.82–22.37) | 14.79 (292.23) | 14.62 (10.36) | 3.87 (2.2) |  |
Non-Ophthalmic | Siponimod | 15 | 20.51 (12.33–34.12) | 20.45 (275.36) | 20.3 (13.26) | 4.34 (2.68) |  |
Non-Ophthalmic | Sildenafil | 15 | 6.14 (3.7-10.21) | 6.14 (64.04) | 6.1 (3.99) | 2.61 (0.94) | Â |
Non-Ophthalmic | Encorafenib | 13 | 19.77 (11.45–34.14) | 19.71 (229.39) | 19.59 (12.4) | 4.29 (2.62) |  |
Non-Ophthalmic | Paclitaxel | 40 | 7.42 (5.42–10.15) | 7.41 (217.31) | 7.28 (5.6) | 2.86 (1.2) |  |